Engineering a long acting, non-biased relaxin agonist using Protein-in-Protein technology
Irina U. Agoulnik(University of South Florida), Alexander I. Agoulnik(Florida International University), Ross A. D. Bathgate(The University of Melbourne), Ronald M. Lindsay(Regeneron (United States)), Elena M Kaftanovskaya(Florida International University), Peter S DiStefano(Zebra Biologics (United States)), Martina Kočan(Discovery Institute), Courtney Myhr(Florida International University), Yingjie Peng(University of Chicago)
Cited by 6
Related Papers
Rethinking dog domestication by integrating genetics, archeology, and biogeography
|Proceedings of the National Academy of Sciences|2012|534
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
A transgenic insertion upstream of Sox9 is associated with dominant XX sex reversal in the mouse
|Nature Genetics|2000|351
Caveolin-1 Is Down-Regulated in Human Ovarian Carcinoma and Acts as a Candidate Tumor Suppressor Gene
|American Journal Of Pathology|2001|279